Domů › Mnohočetný myelom › Kalifornie › Irvine
Klinické studie Mnohočetný myelom v Irvine, CA
14 studií pro Mnohočetný myelom hledá účastníky v lokalitách v Irvine a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
Probíhá náborFáze 2
- City of Hope Orange County Lennar Foundation Cancer Center, Irvine
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
Probíhá náborFáze 1
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 279067, Irvine
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
Probíhá náborFáze 1
- City of Hope Orange County Lennar Foundation Cancer Center, Irvine
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
Probíhá náborFáze 1/2
- City of Hope Irvine Lennar, Irvine
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Probíhá náborFáze 3
- UC Irvine Health Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Probíhá náborFáze 3
- City of Hope Orange County Lennar Foundation Cancer Center, Irvine
Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
Probíhá náborFáze 2
- City of Hope at Irvine Lennar, Irvine
A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma
Probíhá náborFáze 1/2
- City of Hope - Lennar, Irvine
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Probíhá náborFáze 3
- City of Hope Orange County Lennar Foundation Cancer Center, Irvine
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
Probíhá náborFáze 3
- City of Hope - Lennar Foundation Cancer Center, Irvine
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
Probíhá náborFáze 1/2
- Research Site, Irvine
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
Probíhá náborFáze 1/2
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 277911, Irvine
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
Probíhá náborFáze 4
- UCI Health - Irvine Infusion Pharmacy ACC, Irvine
A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- City of Hope at Irvine Lennar, Irvine
Studie Mnohočetný myelom v jiných městech
- New York City, NY60 studií
- Boston, MA42 studií
- Atlanta, GA41 studií
- Houston, TX38 studií
- Durham, NC37 studií
- Nashville, TN32 studií
- Denver, CO27 studií
- Rochester, MN24 studií
- St. Louis, MO24 studií
- Columbus, OH24 studií
- Baldwin Park, CA23 studií
- Chicago, IL22 studií
Další studie v Irvine
- Nemalobuněčný plicní karcinom25 studií
- Rakovina prsu23 studií
- Rakovina (všechny typy)16 studií
- Metastatický karcinom16 studií
- Rakovina plic15 studií
- Rakovina prostaty14 studií
- Rakovina vaječníků12 studií
- Alzheimerova choroba11 studií
- Squamózní buněčný karcinom hlavy a krku11 studií
- Rakovina močového měchýře11 studií
- Kolorektální karcinom10 studií
- Rakovina slinivky břišní10 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.